stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) Revenue
Clover Health Investments, Corp.'s revenue for fiscal 2025 was $1.9B, up 40.3% from $1.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.7B. Over the past ten years it has ranged from $462.3M (fiscal 2019) to $1.9B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 3 consecutive fiscal years. Clover Health Investments, Corp. ranks 10th of 12 Healthcare Plans companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $1.9B | 40.34% |
| FY2024 | $1.4B | 8.77% |
| FY2023 | $1.3B | 14.96% |
| FY2022 | $1.1B | (25.51%) |
| FY2021 | $1.5B | 118.76% |
| FY2020 | $672.9M | 45.56% |
| FY2019 | $462.3M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $759.3M | 2.17% |
| Jun 2026 | $743.2M | (0.80%) |
| Mar 2026 | $749.2M | 53.61% |
| Dec 2025 | $487.7M | (1.80%) |
| 23 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| CI Cigna Group compare | $286.3B |
| CNC Centene Corporation compare | $203.9B |
| ELV Elevance Health, Inc. compare | $201.8B |
| HUM Humana Inc. compare | $154.2B |
| MOH Molina Healthcare, Inc compare | $44.1B |
| OSCR Oscar Health, Inc. compare | $17.5B |
| ALHC Alignment Healthcare, Inc. compare | $4.9B |
| CLOV Clover Health Investments, Corp. | $2.7B |
| PGNY Progyny, Inc. compare | $1.3B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CLOV
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement